NCT07795996

Brief Summary

Thiamine (vitamin B1) is an important nutrient needed for energy metabolism, brain development, and overall health. However, low thiamine intake is a concern in countries where white rice is the main staple since it contains little thiamine. If pregnant or breastfeeding women do not eat enough thiamine, their babies may also become deficient. Severe thiamine deficiency can cause beriberi, which can be life-threatening. Milder deficiency during early life may affect brain development. Healthy pregnant women should eat 1.4 mg thiamine daily. In a previous study in rural Cambodia, study investigators found that giving breastfeeding mothers a higher dose of thiamine (10mg per day) improved their infants' brain development at six months of age. However, supplementation began two weeks after birth. Since much of an infant's brain development occurs in utero, starting mother's supplementation earlier - in pregnancy - may provide greater benefits. Study investigators are now conducting a study with pregnant women in Cambodia. Participants will receive either the usual amount of thiamine found in multiple micronutrient supplements or a higher dose, beginning in pregnancy and continuing until their child is 18 months old. The primary outcome is cognition at 18 months, to see whether higher thiamine intake during pregnancy and early childhood leads to measurable improvements in early brain development.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,972

participants targeted

Target at P75+ for not_applicable

Timeline
30mo left

Started Jun 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress12%
Jun 2026Mar 2029

Study Start

First participant enrolled

June 1, 2026

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 19, 2026

Completed
12 days until next milestone

First Posted

Study publicly available on registry

August 31, 2026

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2028

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2029

Last Updated

August 31, 2026

Status Verified

August 1, 2026

Enrollment Period

2.6 years

First QC Date

August 19, 2026

Last Update Submit

August 27, 2026

Conditions

Keywords

thiamine (vitamin B1)multiple micronutrient supplementsCambodianeurocognitionrandomized controlled trial

Outcome Measures

Primary Outcomes (1)

  • Mullen's Scales of Early Learning "Early Learning Composite" T-score (MSEL-ELC)

    Early Learning Composite (ELC) Standard Score is derived from the sum of the age adjusted T-scores for all but the Gross Motor scales: ELC Standard Score = Visual Reception T-Score + Fine Motor T-Score + Receptive Language T-Score + Expressive Language T-Score ELC Standard Score Mean = 100 ELC Standard Score SD = 15 ELC Standard Score Range (Min/Max) = 49 to 155

    18 months postnatal

Other Outcomes (6)

  • Mullen's Scales of Early Learning "Early Learning Composite" T-score (MSEL-ELC)

    2 weeks and 6 months postnatal

  • Mullen's Scales of Early Learning sub-scales

    2 weeks, 6 months, and 18 months postnatal

  • Global Scales of Early Development (GSED)

    2 weeks, 6 months, and 18 months postnatal

  • +3 more other outcomes

Study Arms (2)

Standard of Care +

PLACEBO COMPARATOR

multiple micronutrient supplement formulations containing the RNI for thiamine: 1.4 mg/d for pregnant/lactating women (from 12-16 weeks pregnancy through 6 months postnatal), and 0.5 mg/d for children (6-18 months postnatal)

Dietary Supplement: Multiple micronutrient supplementation

High-thiamine MMS

EXPERIMENTAL

multiple micronutrient supplement formulations containing a higher dose of daily thiamine: 10 mg/d for pregnant/lactating women (12-16 weeks pregnancy through 6 months postnatal), and 5 mg/d for children (6-18 months postnatal)

Dietary Supplement: Multiple micronutrient supplementation

Interventions

Standard of Care+ group From 12-16 weeks gestation through to 6 months postnatal, women will consume tablets orally. Starting at 6 months postnatal, supplements will then be administered directly to infants as daily liquid supplement drops. Details of supplement contents are found in the full protocol. Multiple micronutrient supplements will include the standard 15 micronutrients included in the United Nations International Multiple Micronutrient Antenatal Preparation Multiple Micronutrient Supplements (UNIMAPP MMS) formulation, which are the same found in standard micronutrient powders designed for children 6-24 months: thiamine, as well as vitamins A, D, E, K, C, B2, B3, B6, B12, folic acid, iodine, zinc, selenium, and copper. "Standard of Care +" and "High thiamine MMS" groups will take supplements that are identical except for thiamine content. Women: 1.4 mg thiamine Children: 0.5 mg thiamine

Standard of Care +

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • women aged 18-45 years
  • (+0) to 15(+6) weeks pregnant, based on last menstrual period
  • planning to breastfeed for at least 6 months

You may not qualify if:

  • consumed thiamine-containing supplements in the preceding 3 months
  • planning on moving out of province in the next year

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Community-based study

Kampong Thom, Cambodia

RECRUITING

Central Study Contacts

Kyly C Whitfield

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, Department of Applied Human Nutrition

Study Record Dates

First Submitted

August 19, 2026

First Posted

August 31, 2026

Study Start

June 1, 2026

Primary Completion (Estimated)

December 31, 2028

Study Completion (Estimated)

March 31, 2029

Last Updated

August 31, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will share

Data will be stored in a repository, and will be made available upon request pending application and approval of the PI.

Locations